Thomas F. Isett

2021

In 2021, Thomas F. Isett earned a total compensation of $4.8M as Executive Chairman, President and Chief Executive Officer at iBio, a 171% increase compared to previous year.

Compensation breakdown

Bonus$759,500
Option Awards$3,539,622
Salary$526,090
Other$14,500
Total$4,839,712

Isett received $3.5M in option awards, accounting for 73% of the total pay in 2021.

Isett also received $759.5K in bonus, $526.1K in salary and $14.5K in other compensation.

Rankings

In 2021, Thomas F. Isett's compensation ranked 2,728th out of 12,415 executives tracked by ExecPay. In other words, Isett earned more than 78.0% of executives.

ClassificationRankingPercentile
All
2,728
out of 12,415
78th
Division
Manufacturing
1,079
out of 5,505
80th
Major group
Chemicals And Allied Products
425
out of 2,375
82nd
Industry group
Drugs
371
out of 2,096
82nd
Industry
Pharmaceutical Preparations
247
out of 1,546
84th
Source: SEC filing on October 26, 2021.

Isett's colleagues

We found two more compensation records of executives who worked with Thomas F. Isett at iBio in 2021.

2021

Randy Maddux

iBio

Chief Operating Officer

2021

Martin Brenner

iBio

Chief Scientific Officer

News

In-depth

You may also like